Nebulabio is a specialized life sciences service provider with a core mission to empower research and drug discovery by unlocking the complexity of the proteome. Our Protein Modification and Detection Platform is built upon over a decade of dedicated expertise in protein chemistry, mass spectrometry, and advanced detection technologies. We serve as a strategic partner to academic laboratories, biotechnology companies, and pharmaceutical developers, offering an integrated suite of services that bridges the critical gap between protein sequence and function. Our team of analytical chemists, biochemists, and bioinformaticians is adept at identifying, quantifying, and validating post-translational modifications (PTMs), and then leveraging this information to develop precise, modification-sensitive detection tools. From mapping phosphorylation networks in signaling pathways to validating specific glycosylation patterns on therapeutic antibodies, our platform provides the data and reagents necessary to drive mechanistic insights and ensure product quality.
☞Introduction to the Protein Modification and Detection Platform
Proteins are not static entities; their function, stability, localization, and interactions are dynamically regulated by a vast array of Post-Translational Modifications (PTMs). These modifications—such as phosphorylation, glycosylation, ubiquitination, acetylation, and methylation—act as molecular switches and codes that dictate cellular behavior. Dysregulation of PTMs is a hallmark of many diseases, including cancer, neurodegeneration, and metabolic disorders.
Our integrated platform is designed to address two fundamental challenges in protein science:
● Comprehensive PTM Analysis (The "What" and "Where"): Precisely identifying which modifications are present on a protein, and mapping their exact locations (sites) within the amino acid sequence.
● Functional Detection & Validation (The "So What"): Developing targeted, highly specific methods to detect and quantify these modified protein forms in complex biological samples, enabling functional studies, biomarker discovery, and quality control.
Unlike fragmented services, our platform offers a seamless workflow. We can take your protein of interest—be it a recombinant protein, a therapeutic antibody, or proteins from cell/tissue lysates—and guide it through a discovery phase (global PTM profiling) to a targeted phase (development of custom detection antibodies or assays). This holistic approach accelerates the translation of proteomic observations into actionable biological understanding and reliable assay reagents.
| ☎ +86-15801534258 | ✉ info@nebulabio.cn | Contact Us ☜☜ |
☞Technology Process of Protein Modification & Detection
Nebulabio’s platform employs a rigorous, multi-stage analytical and development pipeline.

Figure1. Protein Palmitoylation Modification During Viral Infection and Detection Methods of Palmitoylated Proteins.
Phase 1: Sample Preparation & Enrichment
①Phosphorylation: Immobilized metal affinity chromatography (IMAC) or titanium dioxide (TiO2) chromatography. ②Acetylation/Lysine Modifications: Immunoaffinity pulldown with pan-specific antibodies. ③Ubiquitination: Tandem Ubiquitin-Binding Entity (TUBE) affinity purification or di-glycine remnant immunoaffinity (after trypsin digestion). Phase 2: High-Resolution Mass Spectrometry (MS) Analysis
Phase 3: Quantification & Bioinformatics
Phase 4: Custom Detection Tool Development Based on the MS-identified PTM sites, we offer downstream development services:
|
☞Applications of the Protein Modification and Detection Platform
Nebulabio’s platform delivers critical insights and tools across diverse fields:
Cell Signaling & Disease Mechanism Research: Mapping dynamic phosphorylation, ubiquitination, or acetylation events in pathways related to oncology, immunology, and neuroscience to understand disease drivers and identify novel drug targets.
Biopharmaceutical Development & Quality Control:
①Therapeutic Antibody Characterization: Comprehensive analysis of glycosylation profiles (critical for Fc effector function and pharmacokinetics) and other modifications (deamidation, oxidation) to ensure consistency, safety, and efficacy.
②Biosimilarity Assessment: Detailed PTM comparability studies between a biosimilar and its reference product.
Biomarker Discovery & Validation: Identifying disease-specific PTM signatures (e.g., in plasma, urine, or tissue) as potential diagnostic or prognostic biomarkers, followed by development of clinical-grade detection assays.
Epigenetics & Chromatin Biology: Profiling histone modifications (methylation, acetylation) to study gene regulation and epigenetic mechanisms.
Enzyme Kinetics & Substrate Identification: Identifying and quantifying modification sites to determine enzyme specificity and kinetic parameters.
Food & Agricultural Sciences: Analyzing post-harvest protein modifications related to quality, shelf-life, and allergenicity.
☞Nebulabio Service Workflow
We provide a collaborative, milestone-driven service experience from initial consultation to final deliverables.
Step 1: Project Scoping & Consultation
We discuss your biological question, protein target, sample type, and goals (discovery, validation, or reagent development). Together, we design a tailored project plan.
Step 2: Sample Submission & Feasibility Assessment
You provide samples. We perform initial quality checks and may run a pilot analysis to confirm feasibility and optimize protocols.
Step 3: Discovery & Analytical Phase
We execute the agreed-upon PTM enrichment and mass spectrometry workflow. You receive a comprehensive analytical report detailing all identified modifications, site localizations, and quantitative data (if applicable).
Step 4: Data Interpretation & Strategic Planning
Our scientists help interpret the results in the context of your research. We jointly decide on the most important PTM sites for further validation or tool development.
Step 5: Detection Tool Development (Optional)
If proceeding, we initiate custom antibody production or targeted assay development. You receive regular updates during the immunization, screening, and assay optimization phases.
Step 6: Final Delivery & Reporting
The project concludes with the delivery of:
For PTM Analysis: A final report with all raw and processed MS data, annotated spectra, and bioinformatic analysis.
For Detection Tool Development: The purified, QC-validated custom antibody and/or a validated assay protocol, along with performance data.
Our Integrated Service Flowchart:

☞Why Choose Nebulabio’s Platform?
Integrated, End-to-End Expertise: We uniquely combine deep mass spectrometry proficiency with immunoassay development capabilities. This allows us to not only discover PTMs but also build the essential tools to study them functionally, saving you time and coordination effort with multiple vendors.
Focus on High-Quality, Site-Specific Data: Our use of high-resolution mass spectrometry and stringent bioinformatics ensures confident, site-localized PTM identification, moving beyond simple modification identification to precise biological insight.
Customization & Flexibility: We tailor every project. There is no "one-size-fits-all" package. Whether you need a deep dive into the phosphoproteome of a cell line or a targeted glycan analysis on a single antibody, we design the appropriate strategy.
Proven Success with Challenging Targets: Our team has extensive experience with low-abundance modifications, membrane proteins, and complex samples, applying optimized enrichment and analytical strategies to deliver meaningful data where others may fail.
Commitment to Data Integrity & Transparency: We provide all raw data files, detailed methodologies, and clear, interpretable reports. We believe in collaborative science and are available to discuss results and implications in depth.
Accelerated Path to Validated Tools: By integrating discovery and development, we significantly shorten the timeline from an unknown modification to having a validated, specific antibody or assay in hand, accelerating your research or development cycle.
Unlock the functional layer of your proteome. Partner with Nebulabio’s integrated platform to move from protein sequence to modification-aware understanding and precise detection.
For more information, please contact us at info@nebulabio.cn or +86-15801534258.
